Australia markets closed

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.6900+0.0800 (+4.97%)
At close: 04:00PM EDT
1.7100 +0.02 (+1.18%)
After hours: 07:34PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
-
86,346
88,638
145,968
Cost of revenue
-
46,021
36,189
61,619
Gross profit
-
40,325
52,449
84,349
Operating expenses
Research development
-
130,821
174,533
167,382
Selling general and administrative
-
127,332
106,079
127,661
Total operating expenses
-
258,153
280,612
295,043
Operating income or loss
-
-217,828
-228,163
-210,694
Interest expense
-
2,410
1,901
1,472
Total other income/expenses net
-
-878
-847
158
Income before tax
-
-220,683
-227,278
-204,749
Income from continuing operations
-
-220,683
-227,278
-204,749
Net income
-
-220,683
-227,278
-204,749
Net income available to common shareholders
-
-220,683
-227,278
-204,749
Basic EPS
-
-2.24
-2.50
-2.50
Diluted EPS
-
-2.24
-2.50
-2.50
Basic average shares
-
98,471
90,774
81,779
Diluted average shares
-
98,471
90,774
81,779
EBITDA
-
-215,252
-222,530
-201,233